Key clinical recommendation	SOR label	References
Based on the results of the FRISC II and TACTICS-TIMI 18 studies, the updated ACC/AHA guideline recommends an early invasive strategy in patients with UA/NSTEMI and any high-risk indicators (ACC/AHA class I recommendation).	A	1, 2, 4, 5